NO833259L - Metode for kvantitativ bestemmelse av hemoglobinmengden i en biologisk proeve - Google Patents

Metode for kvantitativ bestemmelse av hemoglobinmengden i en biologisk proeve

Info

Publication number: NO833259L
Authority: NO; Norway
Prior art keywords: hemoglobin; sample; porphyrins; porphyrin; derived
Prior art date: 1982-09-13

Application number

NO833259A

Other languages

English (en)

Norwegian (no)

Inventor

Samuel Schwartz

Original Assignee

Univ Minnesota

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-09-13

Filing date

1983-09-12

Publication date

1984-03-14

1983-09-12 Application filed by Univ Minnesota filed Critical Univ Minnesota

1984-03-14 Publication of NO833259L publication Critical patent/NO833259L/no

Links

102000001554 Hemoglobins Human genes 0.000 title claims description 95
108010054147 Hemoglobins Proteins 0.000 title claims description 95
238000000034 method Methods 0.000 title claims description 72
238000012360 testing method Methods 0.000 title description 13
150000004032 porphyrins Chemical class 0.000 claims description 112
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 80
239000000523 sample Substances 0.000 claims description 57
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 52
238000000605 extraction Methods 0.000 claims description 47
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 42
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 21
239000000126 substance Substances 0.000 claims description 19
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 15
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 14
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
238000006243 chemical reaction Methods 0.000 claims description 12
229930002875 chlorophyll Natural products 0.000 claims description 12
235000019804 chlorophyll Nutrition 0.000 claims description 12
ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 12
230000002452 interceptive effect Effects 0.000 claims description 11
210000003608 fece Anatomy 0.000 claims description 10
239000000203 mixture Substances 0.000 claims description 10
235000011056 potassium acetate Nutrition 0.000 claims description 10
150000003839 salts Chemical class 0.000 claims description 10
239000003153 chemical reaction reagent Substances 0.000 claims description 9
239000002904 solvent Substances 0.000 claims description 9
239000002253 acid Substances 0.000 claims description 8
229910000147 aluminium phosphate Inorganic materials 0.000 claims description 7
238000000926 separation method Methods 0.000 claims description 7
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
229910052742 iron Inorganic materials 0.000 claims description 6
239000012620 biological material Substances 0.000 claims description 5
210000004051 gastric juice Anatomy 0.000 claims description 5
239000000049 pigment Substances 0.000 claims description 5
210000002700 urine Anatomy 0.000 claims description 5
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 claims description 4
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 4
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 2
AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 2
CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 claims description 2
239000003960 organic solvent Substances 0.000 claims description 2
STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 claims description 2
229950011008 tetrachloroethylene Drugs 0.000 claims 1
235000019439 ethyl acetate Nutrition 0.000 description 26
239000012071 phase Substances 0.000 description 19
229960000583 acetic acid Drugs 0.000 description 16
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 12
241000894006 Bacteria Species 0.000 description 11
-1 heme compounds Chemical class 0.000 description 11
239000012472 biological sample Substances 0.000 description 9
150000003278 haem Chemical class 0.000 description 8
230000000740 bleeding effect Effects 0.000 description 7
210000001035 gastrointestinal tract Anatomy 0.000 description 7
239000008346 aqueous phase Substances 0.000 description 6
150000001875 compounds Chemical class 0.000 description 6
230000000968 intestinal effect Effects 0.000 description 6
239000012535 impurity Substances 0.000 description 5
238000002955 isolation Methods 0.000 description 5
239000000463 material Substances 0.000 description 4
235000006408 oxalic acid Nutrition 0.000 description 4
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
239000003814 drug Substances 0.000 description 3
244000005709 gut microbiome Species 0.000 description 3
BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 3
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
239000003125 aqueous solvent Substances 0.000 description 2
238000003271 compound fluorescence assay Methods 0.000 description 2
IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000000284 extract Substances 0.000 description 2
239000011790 ferrous sulphate Substances 0.000 description 2
235000003891 ferrous sulphate Nutrition 0.000 description 2
230000006872 improvement Effects 0.000 description 2
159000000014 iron salts Chemical class 0.000 description 2
229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
230000009466 transformation Effects 0.000 description 2
KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
229910004373 HOAc Inorganic materials 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
150000003863 ammonium salts Chemical class 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000010310 bacterial transformation Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000008021 deposition Effects 0.000 description 1
239000000975 dye Substances 0.000 description 1
238000007429 general method Methods 0.000 description 1
239000012362 glacial acetic acid Substances 0.000 description 1
150000002505 iron Chemical class 0.000 description 1
FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
229910000358 iron sulfate Inorganic materials 0.000 description 1
PVFSDGKDKFSOTB-UHFFFAOYSA-K iron(3+);triacetate Chemical compound [Fe+3].CC([O-])=O.CC([O-])=O.CC([O-])=O PVFSDGKDKFSOTB-UHFFFAOYSA-K 0.000 description 1
210000002429 large intestine Anatomy 0.000 description 1
238000005259 measurement Methods 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
150000004033 porphyrin derivatives Chemical class 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000008569 process Effects 0.000 description 1
239000000047 product Substances 0.000 description 1
229950003776 protoporphyrin Drugs 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
238000012113 quantitative test Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
239000001632 sodium acetate Substances 0.000 description 1
235000017281 sodium acetate Nutrition 0.000 description 1
ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 description 1
229940039790 sodium oxalate Drugs 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0038—Devices for taking faeces samples; Faecal examination devices
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y10T436/146666—Bile pigment
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
- Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Pathology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Cell Biology (AREA)
Surgery (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Heart & Thoracic Surgery (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Physics & Mathematics (AREA)
Investigating Or Analysing Biological Materials (AREA)
Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

NO833259A 1982-09-13 1983-09-12 Metode for kvantitativ bestemmelse av hemoglobinmengden i en biologisk proeve NO833259L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/418,282 US4567148A (en)	1980-09-24	1982-09-13	Method for quantitatively determining the amount of hemoglobin in a biological sample

Publications (1)

Publication Number	Publication Date
NO833259L true NO833259L (no)	1984-03-14

Family

ID=23657461

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO833259A NO833259L (no)	1982-09-13	1983-09-12	Metode for kvantitativ bestemmelse av hemoglobinmengden i en biologisk proeve

Country Status (10)

Country	Link
US (1)	US4567148A (da)
EP (1)	EP0103281A3 (da)
JP (1)	JPS5977357A (da)
AU (1)	AU564710B2 (da)
CA (1)	CA1213199A (da)
DK (1)	DK413683A (da)
FI (1)	FI76434C (da)
NO (1)	NO833259L (da)
NZ (1)	NZ205435A (da)
ZA (1)	ZA836628B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4526869A (en) *	1980-09-24	1985-07-02	Regents Of The University Of Minnesota	Method for quantitatively determining the concentration of hemoglobin in a biological sample
JPS59180459A (ja) *	1983-03-31	1984-10-13	Sato Yakugaku Kenkyusho:Kk	血液中のポルフイリン類の定量法
US5182191A (en) *	1988-10-14	1993-01-26	Pacific Biotech, Inc.	Occult blood sampling device and assay
EP2790564B1 (en) *	2011-12-15	2026-01-21	Given Imaging Ltd.	Device, system and method for in-vivo detection of bleeding in the gastrointestinal tract
US9795330B2 (en)	2011-12-15	2017-10-24	Given Imaging Ltd.	Device, system and method for in-vivo detection of bleeding in the gastrointestinal tract
CN119958932B (zh) *	2025-02-20	2025-11-21	天津大学	一种卟啉类化合物的提取和检测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3874853A (en) *	1972-11-16	1975-04-01	Damon Corp	Process for determining the concentration of inorganic phosphates in human fluids
US4035150A (en) *	1975-09-24	1977-07-12	The United States Of America As Represented By The Secretary Of The Department Of Health, Education And Welfare	Test for occult blood in an emulsified aqueous/organic system
US4378971A (en) *	1980-09-24	1983-04-05	Regents Of The University Of Minnesota	Method and apparatus for quantitatively determining the level of hemoglobin in a biological sample

1982
- 1982-09-13 US US06/418,282 patent/US4567148A/en not_active Expired - Lifetime
1983
- 1983-08-31 NZ NZ205435A patent/NZ205435A/en unknown
- 1983-09-06 ZA ZA836628A patent/ZA836628B/xx unknown
- 1983-09-08 EP EP83108898A patent/EP0103281A3/en not_active Withdrawn
- 1983-09-09 FI FI833226A patent/FI76434C/fi not_active IP Right Cessation
- 1983-09-12 NO NO833259A patent/NO833259L/no unknown
- 1983-09-12 DK DK413683A patent/DK413683A/da unknown
- 1983-09-13 AU AU19095/83A patent/AU564710B2/en not_active Ceased
- 1983-09-13 CA CA000436593A patent/CA1213199A/en not_active Expired
- 1983-09-13 JP JP58169117A patent/JPS5977357A/ja active Pending

Also Published As

Publication number	Publication date
DK413683A (da)	1984-03-14
ZA836628B (en)	1984-05-30
CA1213199A (en)	1986-10-28
EP0103281A3 (en)	1986-08-13
FI833226A0 (fi)	1983-09-09
AU1909583A (en)	1984-03-22
FI76434B (fi)	1988-06-30
US4567148A (en)	1986-01-28
EP0103281A2 (en)	1984-03-21
FI76434C (fi)	1988-10-10
AU564710B2 (en)	1987-08-20
NZ205435A (en)	1985-09-13
FI833226L (fi)	1984-03-14
JPS5977357A (ja)	1984-05-02
DK413683D0 (da)	1983-09-12

Publication	Publication Date	Title
DE69427131T2 (de)	2001-11-29	Siebtest zur früherkennung von kolorektalen neoplasien
EP0121317B2 (en)	1991-11-27	Peroxidase activity detection composition
Robbie et al.	1943	Rapid clinical determination of urinary 17-ketosteroids
US4277250A (en)	1981-07-07	Methods for detecting and quantifying occult blood
HU195005B (en)	1988-03-28	Method and apparatus for quantitative determination of hemoglobin in biologic samples
Carruthers et al.	1973	Free fatty acid estimation by a semi-automated fluorimetric method
CA2158431A1 (en)	1994-09-29	Method of gastrointestinal cancer testing
Cripps et al.	1967	Fluorescing erythrocytes and porphyrin screening tests on urine, stool, and blood: Investigation of photosensitivity
CN112852928A (zh)	2021-05-28	一种多重核酸扩增产物检测方法及试剂盒
Berry et al.	1973	Emergency toxicological screening for drugs commonly taken in overdose
NO833259L (no)	1984-03-14	Metode for kvantitativ bestemmelse av hemoglobinmengden i en biologisk proeve
US5460969A (en)	1995-10-24	Method for differentiating the source of occult gastrointestinal bleeding
Coch et al.	1973	A modified procedure for evaluation of the lecithin/sphingomyelin ratio in amniotic fluid
Finkelstein	1948	Microdetermination of Steroid Estrogens in Urine by Fluorometry.
NO841234L (no)	1984-10-01	Fremgangsmaate for kvantitativ bestemmelse av konsentrasjonen av hemoglobin i en biologisk proeve
Bloem	1933	The relative value of clinical tests for blood
EP0172841B1 (en)	1990-08-16	Method for detecting malign proliferation
Kahn	1924	The Kahn precipitation test for syphilis
CN104897903B (zh)	2017-07-14	一种亨氏小体(Heinz Body)检测试剂盒
De Zeeuw et al.	1986	Multicenter evaluation of ultrafiltration, dialysis, and thermal coagulation as sample pretreatment methods for the colorimetric determination of paraquat in blood and tissues
Tyson	2025	A Guide to the Practical Examination of Urine
SU1483341A1 (ru)	1989-05-30	Способ определени амизила
Bjerre et al.	1967	Determination of Neutral Urinary 17-Oxosteroids with Hydroxide of Hyamine 1O-X in the Zimmermann Reaction
Bloom et al.	1924	A simple method for the determination of phenoltetrachlorphthalein in blood serum
Vaughan	1932	The Examination of Urine for Indol